$ASRT

$ASRT (Assertio Therapeutics) why I invested in them and why I´m bullish. 250% upside according to analysts. TOP 1 most mentioned stock the past 2 days here.

Assertio Therapeutics has a robust portfolio of FDA-approved neurology, inflammation, and pain medications and proprietary Acuform drug delivery technology with partnership opportunities. The company has recovered from prior bankruptcy risk and achieved cost reductions and synergies through its Zyla merger, positioning it for 250% upside according to analyst targets.